EGFR and breast carcinoma: While the accumulating data just described show that IGF-1R operates through signaling cross-talk with estrogen-ER signaling and EGFR/HER2 regulatory pathways in antiestrogen-resistant breast cancer cells, the ER-independent role of IGF-1R signaling in antiestrogen resistance is poorly understood [1,4].